Basel Medical Group Income Statement

Financials in millions SGD. Fiscal year is July - June.

Millions SGD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Revenue	14.55	11.32	10.05	9.7	10.66
Revenue Growth	28.55%	12.63%	3.60%	-8.98%	-
Cost of Revenue	12.67	8.95	5.89	5.58	6.21
Gross Profit	1.88	2.37	4.16	4.12	4.45
Selling, General & Admin	0.03	0.14	0	0.02	0.01
Depreciation & Amortization Expenses	2.89	1.18	0.53	0.56	0.58
Other Operating Expenses	3.56	13.65	1.51	1.58	1.71
Total Operating Expenses	6.48	14.97	2.04	2.16	2.3
Operating Income	-4.6	-12.6	2.12	1.96	2.15
Interest Expense	-0.32	-0.2	-0.18	-0.24	-0.32
Other Non-Operating Income (Expense)	4.87	1.75	0.46	0.41	0.55
Total Non-Operating Income (Expense)	4.55	1.55	0.28	0.17	0.23
Pretax Income	-10.4	-11.05	2.4	2.13	2.39
Provision for Income Taxes	-	-0.42	0.33	-	-
Net Income	-10.16	-10.64	2.07	1.78	2.39
Minority Interest in Earnings	-0.11	-0	-	-	-
Net Income to Common	-10.05	-10.64	2.07	1.78	2.39
Net Income Growth	-	-	16.23%	-25.27%	-
Shares Outstanding (Basic)	19	2	1	1	1
Shares Outstanding (Diluted)	19	2	1	1	1
Shares Change	66.47%	15.60%	-	-	-
EPS (Basic)	-6.81	-6.84	1.56	1.32	1.44
EPS (Diluted)	-6.81	-6.84	1.56	1.32	1.44
EPS Growth	-	-	18.18%	-8.33%	-
Free Cash Flow	-2.56	-4.6	2.5	2.59	2.7
Free Cash Flow Growth	-	-	-3.56%	-4.07%	-
Free Cash Flow Per Share	-0.14	-2.94	1.85	1.92	2.00
Gross Margin	12.92%	20.93%	41.43%	42.44%	41.74%
Operating Margin	-31.59%	-111.33%	21.09%	20.18%	20.20%
Profit Margin	-69.81%	-93.96%	20.62%	18.38%	22.39%
FCF Margin	-17.58%	-40.64%	24.89%	26.74%	25.37%
EBITDA	-1.71	-11.42	2.65	2.51	2.73
EBITDA Margin	-11.75%	-100.89%	26.35%	25.92%	25.61%
EBIT	-4.6	-12.6	2.12	1.96	2.15
EBIT Margin	-31.59%	-111.33%	21.09%	20.18%	20.20%
Effective Tax Rate	-	3.78%	13.80%	0.00%	0.00%

SEC Filings: 10-K · 10-Q